Saunders C (1975) The care of the dying patient and his family. Doc Med Ethics. https://doi.org/10.1080/13520806.1972.11759235

Article  PubMed  Google Scholar 

Soffietti R, Kocher M, Abacioglu UM, Villa S, Fauchon F, Baumert BG, Fariselli L, Tzuk-Shina T, Kortmann RD, Carrie C, Ben Hassel M, Kouri M, Valeinis E, van den Berge D, Mueller RP, Tridello G, Collette L, Bottomley A (2013) A European Organisation for Research and Treatment of Cancer phase III trial of adjuvant whole-brain radiotherapy versus observation in patients with one to three brain metastases from solid tumors after surgical resection or radiosurgery: quality-of-life results. J Clin Oncol 31:65–72. https://doi.org/10.1200/JCO.2011.41.0639

Article  PubMed  Google Scholar 

Kamp MA, von Sass C, Januzi D, Dibue M, Libourius K, Lawson McLean AC, Baumgarten P, Lawson McLean A, Dinc N, Senft CA (2023) Frequency of social burden and underage children in neuro-oncological patients. J Cancer Res Clin Oncol 149:15911–15922. https://doi.org/10.1007/s00432-023-05338-1

Article  CAS  PubMed  PubMed Central  Google Scholar 

Barnholtz-Sloan JS, Sloan AE, Davis FG, Vigneau FD, Lai P, Sawaya RE (2004) Incidence proportions of brain metastases in patients diagnosed (1973 to 2001) in the Metropolitan Detroit Cancer Surveillance System. J Clin Oncol 22:2865–2872. https://doi.org/10.1200/JCO.2004.12.149

Article  PubMed  Google Scholar 

Ostrom QT, Wright CH, Barnholtz-Sloan JS (2018) Brain metastases: epidemiology. Handb Clin Neurol 149:27–42. https://doi.org/10.1016/B978-0-12-811161-1.00002-5

Article  PubMed  Google Scholar 

Singh K, Saxena S, Khosla AA, McDermott MW, Kotecha RR, Ahluwalia MS (2022) Update on the management of brain metastasis. Neurotherapeutics 19:1772–1781. https://doi.org/10.1007/s13311-022-01312-w

Article  PubMed  PubMed Central  Google Scholar 

Lamba N, Wen PY, Aizer AA (2021) Epidemiology of brain metastases and leptomeningeal disease. Neuro Oncol 23:1447–1456. https://doi.org/10.1093/neuonc/noab101

Article  PubMed  PubMed Central  Google Scholar 

Patchell RA, Tibbs PA, Walsh JW, Dempsey RJ, Maruyama Y, Kryscio RJ, Markesbery WR, Macdonald JS, Young B (1990) A randomized trial of surgery in the treatment of single metastases to the brain. N Engl J Med 322:494–500. https://doi.org/10.1056/nejm199002223220802

Article  CAS  PubMed  Google Scholar 

Kocher M, Soffietti R, Abacioglu U, Villa S, Fauchon F, Baumert BG, Fariselli L, Tzuk-Shina T, Kortmann RD, Carrie C, Ben Hassel M, Kouri M, Valeinis E, van den Berge D, Collette S, Collette L, Mueller RP (2011) Adjuvant whole-brain radiotherapy versus observation after radiosurgery or surgical resection of one to three cerebral metastases: results of the EORTC 22952–26001 study. J Clin Oncol 29:134–141. https://doi.org/10.1200/JCO.2010.30.1655

Article  PubMed  Google Scholar 

Brown PD, Ballman KV, Cerhan JH, Anderson SK, Carrero XW, Whitton AC, Greenspoon J, Parney IF, Laack NNI, Ashman JB, Bahary JP, Hadjipanayis CG, Urbanic JJ, Barker FG 2nd, Farace E, Khuntia D, Giannini C, Buckner JC, Galanis E, Roberge D (2017) Postoperative stereotactic radiosurgery compared with whole brain radiotherapy for resected metastatic brain disease (NCCTG N107C/CEC.3): a multicentre, randomised, controlled, phase 3 trial. Lancet Oncol 18:1049–1060. https://doi.org/10.1016/S1470-2045(17)30441-2

Article  PubMed  PubMed Central  Google Scholar 

Sperduto PW, Mesko S, Li J, Cagney D, Aizer A, Lin NU, Nesbit E, Kruser TJ, Chan J, Braunstein S, Lee J, Kirkpatrick JP, Breen W, Brown PD, Shi D, Shih HA, Soliman H, Sahgal A, Shanley R, Sperduto WA, Lou E, Everett A, Boggs DH, Masucci L, Roberge D, Remick J, Plichta K, Buatti JM, Jain S, Gaspar LE, Wu CC, Wang TJC, Bryant J, Chuong M, An Y, Chiang V, Nakano T, Aoyama H, Mehta MP (2020) Survival in patients with brain metastases: summary report on the updated diagnosis-specific graded prognostic assessment and definition of the eligibility quotient. J Clin Oncol 38:3773–3784. https://doi.org/10.1200/JCO.20.01255

Article  CAS  PubMed  PubMed Central  Google Scholar 

Kluger BM, Hudson P, Hanson LC, Buzgova R, Creutzfeldt CJ, Gursahani R, Sumrall M, White C, Oliver DJ, Pantilat SZ, Miyasaki J (2023) Palliative care to support the needs of adults with neurological disease. Lancet Neurol 22:619–631. https://doi.org/10.1016/S1474-4422(23)00129-1

Article  PubMed  Google Scholar 

Rapp M, Schipmann S, Hoffmann K, Wiewrodt R, Steiger H-J, Kamp M, Stummer W, Wiewrodt D, Sabel M (2018) Impact of distress screening algorithm for psycho-oncological needs in neurosurgical patients. Oncotarget 9:31650

Article  PubMed  PubMed Central  Google Scholar 

van Oorschot B, Jentschke E, Kessler AF, Wittig A, Kamp M (2023) Dringende Notwendigkeit für strukturiertes Symptom- und Belastungsscreening bei Patienten mit primären und sekundären Hirntumoren. Die Onkologie 29:984–990. https://doi.org/10.1007/s00761-023-01417-7

Article  Google Scholar 

World Health Organization (2002) WHO definition of palliative care. http://www.who.int/cancer/palliative/definition/en/. Accessed 16 Sep 2019

von Elm E, Altman DG, Egger M, Pocock SJ, Gotzsche PC, Vandenbroucke JP, Initiative S (2007) The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement: guidelines for reporting observational studies. Lancet 370:1453–1457. https://doi.org/10.1016/S0140-6736(07)61602-X

Article  Google Scholar 

Bundesinstitut für Arzneimittel und Medizinprodukte (BfArM) (2024) Internationale statistische Klassifikation der Krankheiten und verwandter Gesundheitsprobleme, 10. Revision, German Modification, Version 2023. https://klassifikationen.bfarm.de/icd-10-gm/kode-suche/htmlgm2023/index.htm. Accessed 21 Feb 2024

Bundesinstitut für Arzneimittel und Medizinprodukte (BfArM) (2024) OPS Version 2023. Bundesinstitut für Arzneimittel und Medizinprodukte (BfArM). https://klassifikationen.bfarm.de/ops/kode-suche/htmlops2023/index.htm. Accessed 16 Jun 2024

Charlson M, Szatrowski TP, Peterson J, Gold J (1994) Validation of a combined comorbidity index. J Clin Epidemiol 47:1245–1251. https://doi.org/10.1016/0895-4356(94)90129-5

Article  CAS  PubMed  Google Scholar 

Hugel M, Stohr J, Kuhnt T, Nagler F, Papsdorf K, Klagges S, Hambsch P, Guresir E, Nicolay NH, Seidel C (2024) Long-term survival in patients with brain metastases-clinical characterization of a rare scenario. Strahlenther Onkol 200:335–345. https://doi.org/10.1007/s00066-023-02123-4

Article  CAS  PubMed  Google Scholar 

Kamp MA, Fischer I, Buhner J, Turowski B, Cornelius JF, Steiger HJ, Rapp M, Slotty PJ, Sabel M (2016) 5-ALA fluorescence of cerebral metastases and its impact for the local-in-brain progression. Oncotarget 7:66776–66789. https://doi.org/10.18632/oncotarget.11488

Article  PubMed  PubMed Central  Google Scholar 

Kamp MA, Munoz-Bendix C, Mijderwijk HJ, Turowski B, Dibue-Adjei M, von Sass C, Cornelius JF, Steiger HJ, Rapp M, Sabel M (2019) Is 5-ALA fluorescence of cerebral metastases a prognostic factor for local recurrence and overall survival? J Neurooncol 141:547–553. https://doi.org/10.1007/s11060-018-03066-y

Article  CAS  PubMed  Google Scholar 

Kamp MA, Rapp M, Buhner J, Slotty PJ, Reichelt D, Sadat H, Dibue-Adjei M, Steiger HJ, Turowski B, Sabel M (2015) Early postoperative magnet resonance tomography after resection of cerebral metastases. Acta Neurochir (Wien) 157:1573–1580. https://doi.org/10.1007/s00701-015-2479-4

Article  PubMed  Google Scholar 

Junger ST, Pennig L, Schodel P, Goldbrunner R, Friker L, Kocher M, Proescholdt M, Grau S (2021) The debatable benefit of gross-total resection of brain metastases in a comprehensive treatment setting. Cancers (Basel). https://doi.org/10.3390/cancers13061435

Article  PubMed  Google Scholar 

Vogelbaum MA, Brown PD, Messersmith H, Brastianos PK, Burri S, Cahill D, Dunn IF, Gaspar LE, Gatson NTN, Gondi V, Jordan JT, Lassman AB, Maues J, Mohile N, Redjal N, Stevens G, Sulman E, van den Bent M, Wallace HJ, Weinberg JS, Zadeh G, Schiff D (2022) Treatment for brain metastases: ASCO-SNO-ASTRO Guideline. J Clin Oncol 40:492–516. https://doi.org/10.1200/JCO.21.02314

Article  CAS  PubMed  Google Scholar 

Le Rhun E, Devos P, Weller J, Seystahl K, Mo F, Compter A, Berghoff AS, Jongen JLM, Wolpert F, Ruda R, Brandsma D, van den Bent M, Preusser M, Herrlinger U, Weller M (2021) Prognostic validation and clinical implications of the EANO ESMO classification of leptomeningeal metastasis from solid tumors. Neuro Oncol 23:1100–1112. https://doi.org/10.1093/neuonc/noaa298

Article  PubMed  Google Scholar 

Hoang-Xuan K, Deckert M, Ferreri AJM, Furtner J, Gallego Perez-Larraya J, Henriksson R, Hottinger AF, Kasenda B, Lefranc F, Lossos A, McBain C, Preusser M, Roth P, Ruda R, Schlegel U, Soffietti R, Soussain C, Taphoorn MJB, Touitou V, Weller M, Bromberg JEC (2023) European Association of Neuro-Oncology (EANO) guidelines for treatment of primary central nervous system lymphoma (PCNSL). Neuro Oncol 25:37–53. https://doi.org/10.1093/neuonc/noac196

Article  CAS  PubMed  Google Scholar 

Le Rhun E, Guckenberger M, Smits M, Dummer R, Bachelot T, Sahm F, Galldiks N, de Azambuja E, Berghoff AS, Metellus P, Peters S, Hong YK, Winkler F, Schadendorf D, van den Bent M, Seoane J, Stahel R, Minniti G, Wesseling P, Weller M, Preusser M, Board EE (2021) EANO-ESMO Clinical Practice Guidelines for diagnosis, treatment and follow-up of patients with brain metastasis from solid tumours. Ann Oncol 32:1332–1347. https://doi.org/10.1016/j.annonc.2021.07.016

Article  PubMed  Google Scholar 

Le Rhun E, Weller M, van den Bent M, Brandsma D, Furtner J, Ruda R, Schadendorf D, Seoane J, Tonn JC, Wesseling P, Wick W, Minniti G, Peters S, Curigliano G, Preusser M, Committee EG (2023) Leptomeningeal metastasis from solid tumours: